# Equity Research Update: First Solar, Inc. (NASDAQ: FSLR)
**Analyst:** Senior Equity Research | **Date:** Q2 2026 | **Price:** $234.60 | **Mkt Cap:** $25.2B
**Prior Thesis Date:** 2026-05-02 ($211.71, Conviction 7/10, Monitoring)
---
WHAT HAS CHANGED SINCE LAST THESIS
1. **Price action:** Stock up ~10.8% in 10 days; +9.33% in last week alone (source: yfinance). No fundamental data point has materially changed in this short window — this is sentiment/multiple expansion, not earnings revision.
2. **New data point — China's $3B US clean tech exit (Financial Post, 2026-05-13):** This is incrementally **bullish for FSLR's competitive moat** in the U.S. market, as Chinese-affiliated solar capacity continues to face structural barriers (tariffs, UFLPA enforcement, IRA domestic content rules). Reinforces the "U.S. domestic champion" leg of the thesis.
3. **Analyst sentiment:** Consensus target ($246.21) is now only ~5% above spot — the margin of safety on Street estimates has compressed materially since our last review (was ~16% upside).
4. **Valuation:** Forward P/E now ~9.76 vs prior review — still inexpensive on forward earnings, but stock has run ahead of any new fundamental catalyst.
---
1. THESIS SUMMARY
First Solar designs and manufactures **cadmium telluride (CdTe) thin-film photovoltaic modules**, a chemistry distinct from the crystalline silicon panels that dominate the global solar market. The company operates manufacturing capacity in Ohio, Alabama, Louisiana, India, Vietnam, and Malaysia, with rapidly expanding U.S. domestic capacity. FSLR is the **largest U.S.-headquartered solar module manufacturer** and the primary beneficiary of Inflation Reduction Act (IRA) Section 45X advanced manufacturing production tax credits, which monetize at approximately $0.17/watt produced domestically (source: IRA statute, FSLR 10-K disclosures).
The **core investment thesis** is that FSLR is a structurally protected U.S. utility-scale solar oligopolist whose CdTe technology is exempt from the polysilicon supply chain dominated by China — making it the de facto choice for U.S. utility developers seeking IRA domestic content adders and avoidance of Uyghur Forced Labor Prevention Act (UFLPA) detention risk. Backlog visibility extends through ~2030, locking in pricing and volumes that most cyclical industrials would envy (source: FSLR Q4 2025 10-K, contracted backlog disclosures).
The **moat** rests on three pillars: (1) **proprietary CdTe technology** with 20+ years of accumulated manufacturing know-how that has no near-term Chinese competitor; (2) **trade policy protection** via tariffs, AD/CVD duties, UFLPA, and IRA structure favoring U.S.-made modules; (3) **scale and capital intensity** — competitors would need years and billions to replicate U.S. domestic capacity.
---
2. BULL CASE
**IRA 45X is a cash machine:** At full ramp (~14 GW U.S. capacity targeted by 2026), 45X credits alone could generate $2.0–2.4B in annual tax credit revenue, a substantial portion of which flows directly to operating income (source: FSLR capacity guidance, IRA statute). FCF of $1.15B TTM is real and growing.
**Backlog provides multi-year revenue visibility:** Contracted backlog covers production well into the late decade with ASPs largely locked in — a rare characteristic for a commodity-adjacent manufacturer, smoothing through solar pricing cycles (source: FSLR investor disclosures).
**Secular AI/data-center power demand:** Hyperscaler power purchase agreements are accelerating. Utility-scale solar + storage is the fastest-to-deploy bulk generation source, and hyperscalers strongly prefer U.S.-made, UFLPA-clean modules — directly favoring FSLR.
**Reinforced China decoupling:** The Financial Post (2026-05-13) report on Chinese capital exiting U.S. clean tech reinforces that FSLR's competitive set in the U.S. is narrowing, not widening.
---
3. BEAR CASE
**IRA political risk remains the dominant overhang:** A repeal, narrowing, or accelerated phase-down of 45X or domestic content adders under the current administration could vaporize 30–50% of forward earnings power. This is a binary, non-diversifiable policy risk.
**Crystalline silicon ASPs remain depressed globally:** Global poly/wafer/cell prices remain near cycle lows. While FSLR's U.S. contracts are insulated, any contract renegotiation pressure, defaults, or modification fees from customers (a recurring issue in 2023-2024) could reappear.
**Technology risk:** CdTe's efficiency lead is not permanent. TOPCon and HJT silicon technologies continue improving; perovskite tandem cells loom. FSLR's R&D must keep CdTe efficiency trajectory competitive or the cost-per-watt advantage erodes.
**Valuation has run ahead of catalysts:** At $234, the stock is within 5% of consensus target with no new fundamental data point since the last update. Sentiment-driven rallies in the absence of earnings revision warrant caution.
---
4. EXIT CONDITIONS
I would abandon or materially downgrade this thesis if any of the following occur:
1. **Legislative repeal or material reduction of IRA Section 45X** before 2030 phase-down schedule.
2. **Backlog erosion >15%** from peak via cancellations, defaults, or contract modifications (signals customer/end-market deterioration).
3. **Gross margin compression below 30%** for two consecutive quarters (would indicate either ASP pressure or 45X economics deterioration).
4. **Loss of CdTe technology leadership** — efficiency gap vs. leading TOPCon/HJT silicon closes to <1% or commercial perovskite-tandem competitor emerges with cost parity.
5. **Major capital allocation misstep** — debt-funded large acquisition outside core competency.
---
5. 5-YEAR EXPECTED OUTCOME RANGE
| Scenario | 2031 Price Target | Implied CAGR | Key Assumptions |
|---|---|---|---|
| **Bull** | $475–550 | ~16–18% | IRA fully intact, capacity reaches 25GW, $35+ EPS, 14-15x multiple, hyperscaler demand sustained |
| **Base** | $325–380 | ~7–10% | IRA preserved with minor amendments, capacity at 20GW, $30 EPS, 11-12x multiple |
| **Bear** | $110–150 | (-9%)–(-13%) | IRA materially curtailed, backlog erosion, margin compression to 25%, multiple compresses to 7-8x on $18 EPS |
The **wide outcome range is driven almost entirely by IRA policy risk** — a single binary that no fundamental analysis can fully resolve. This is why conviction stays moderate.
---
CONVICTION UPDATE
Fundamentals remain intact and the competitive position has marginally strengthened (China exit confirmation). However, the 11% price rally without commensurate fundamental data degrades the risk/reward at $234.60 vs. our prior entry at $211.71. **Margin of safety to consensus target has narrowed from 16% to 5%.** I am holding conviction at 7/10 and maintaining "monitoring" status — I would want to see either (a) a pullback toward $200–215, or (b) firmer political clarity on IRA preservation before moving to a recommendation.
```json